会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • CONTINUOUS ANALYTE SENSORS AND METHODS OF MAKING SAME
    • 连续分析仪传感器及其制作方法
    • WO2011003036A3
    • 2011-04-14
    • PCT/US2010040839
    • 2010-07-01
    • DEXCOM INCBOOCK ROBERTJACKSON JEFFZHANG HUASHIMITCHELL JASON
    • BOOCK ROBERTJACKSON JEFFZHANG HUASHIMITCHELL JASON
    • A61B5/155A61B5/145A61B5/157
    • A61B5/1473A61B5/14503A61B5/1451A61B5/14517A61B5/14532A61B5/14546A61B5/14865A61B2560/0223A61B2562/0209A61B2562/043A61B2562/125B05C3/10
    • Described here are embodiments of processes and systems for the continuous manufacturing of implantable continuous analyte sensors. In some embodiments, a method is provided for sequentially advancing an elongated conductive body through a plurality of stations, each configured to treat the elongated conductive body. In some of these embodiments, one or more of the stations is configured to coat the elongated conductive body using a meniscus coating process, whereby a solution formed of a polymer and a solvent is prepared, the solution is continuously circulated to provide a meniscus on a top portion of a vessel holding the solution, and the elongated conductive body is advanced through the meniscus. The method may also comprise the step of removing excess coating material from the elongated conductive body by advancing the elongated conductive body through a die orifice. For example, a provided elongated conductive body (510) is advanced through a pre-coating treatment station (520), through a coating station 530, through a thickness control station (540), through a drying or curing station (550), through a thickness measurement station (560), and through a post-coating treatment station (570).
    • 这里描述了用于连续制造可植入的连续分析物传感器的方法和系统的实施方案。 在一些实施例中,提供了一种方法,用于顺序地将细长导电体穿过多个工位,每个工位都构造成处理细长导电体。 在这些实施例中的一些实施例中,一个或多个工位被配置为使用弯液面涂覆工艺涂覆细长导电体,由此制备由聚合物和溶剂形成的溶液,所述溶液被连续循环以在 保持溶液的容器的顶部,并且细长导电体前进通过弯液面。 该方法还可以包括通过使细长导电体通过模头孔从细长导电体去除多余涂层材料的步骤。 例如,所提供的细长导电体(510)穿过预涂处理站(520),穿过涂覆站530穿过厚度控制站(540),通过干燥或固化站(550),通过 厚度测量站(560),并通过后涂层处理站(570)。
    • 4. 发明申请
    • CONTINUOUS ANALYTE SENSORS AND METHODS OF MAKING SAME
    • 连续分析传感器及其制作方法
    • WO2011003036A2
    • 2011-01-06
    • PCT/US2010/040839
    • 2010-07-01
    • DEXCOM, INC.BOOCK, RobertJACKSON, JeffZHANG, HuashiMITCHELL, Jason
    • BOOCK, RobertJACKSON, JeffZHANG, HuashiMITCHELL, Jason
    • A61B5/155A61B5/145A61B5/157
    • A61B5/1473A61B5/14503A61B5/1451A61B5/14517A61B5/14532A61B5/14546A61B5/14865A61B2560/0223A61B2562/0209A61B2562/043A61B2562/125B05C3/10
    • Described here are embodiments of processes and systems for the continuous manufacturing of implantable continuous analyte sensors. In some embodiments, a method is provided for sequentially advancing an elongated conductive body through a plurality of stations, each configured to treat the elongated conductive body. In some of these embodiments, one or more of the stations is configured to coat the elongated conductive body using a meniscus coating process, whereby a solution formed of a polymer and a solvent is prepared, the solution is continuously circulated to provide a meniscus on a top portion of a vessel holding the solution, and the elongated conductive body is advanced through the meniscus. The method may also comprise the step of removing excess coating material from the elongated conductive body by advancing the elongated conductive body through a die orifice. For example, a provided elongated conductive body 510 is advanced through a pre-coating treatment station 520, through a coating station 530, through a thickness control station 540, through a drying or curing station 550, through a thickness measurement station 560, and through a post-coating treatment station 570.
    • 这里描述了用于连续制造可植入的连续分析物传感器的方法和系统的实施方案。 在一些实施例中,提供了一种用于使细长导电体顺序地前进穿过多个台的方法,每个台被构造成处理细长导电体。 在这些实施例中的一些实施例中,一个或多个工位被配置为使用弯液面涂覆工艺涂覆细长导电体,由此制备由聚合物和溶剂形成的溶液,该溶液被连续循环以在 保持溶液的容器的顶部,并且细长导电体前进通过弯液面。 该方法还可以包括通过使细长导电体通过模头孔从细长导电体去除多余涂层材料的步骤。 例如,提供的细长导电体510通过预涂处理站520,穿过涂覆站530,通过厚度控制站540,穿过干燥或固化站550,穿过厚度测量站560,并通过 后涂层处理站570。
    • 5. 发明申请
    • WOUND HEALING POLYMER COMPOSITIONS AND METHODS FOR USE THEREOF
    • WOUND HEALING POLYMER组合物及其使用方法
    • WO2005112587A2
    • 2005-12-01
    • PCT/US2005/016678
    • 2005-05-12
    • MEDIVAS, LLCCARPENTER, Kenneth, W.ZHANG, HuashiMcCARTHY, Brendan, J.SZINAI, IstvanTURNELL, William, G.GOPALAN, Sindhu, M.
    • CARPENTER, Kenneth, W.ZHANG, HuashiMcCARTHY, Brendan, J.SZINAI, IstvanTURNELL, William, G.GOPALAN, Sindhu, M.
    • A61K35/44
    • A61K35/44A61K9/0024A61K38/00A61K47/34A61K47/59A61K47/593A61K47/595A61L15/26A61L15/44A61L15/60A61L15/64A61L26/0019A61L26/0066A61L31/10A61L31/148A61L2300/252A61L2300/412A61L2300/414A61L2300/416A61L2300/604A61L2300/64C08L77/12C08L79/02
    • The present invention provides bioactive polymer compositions that can be formulated to release a wound healing agent at a controlled rate by adjusting the various components of the composition. The composition can be used in an external wound dressing, as a polymer implant for delivery of the wound healing agent to an internal body site, or as a coating on the surface of an implantable surgical device to deliver wound healing agents that are covalently attached to a biocompatible, biodegradable polymer and/or embedded within a hydrogel. Methods of using the invention bioactive polymer compositions to promote natural healing of wounds, especially chronic wounds, are also provided. Examples of biodegradable copolymer polyesters useful in forming the blood­-compatible, hydrophilic layer or coating include copolyester amides, copolyester urethanes, glycolide-lactide copolymers, glycolide-caprolactone copolymers, poly-3-hydroxy butyrate­valerate copolymers, and copolymers of the cyclic diester monomer, 3­(S)[(alkyloxycarbonyl)methyl]-1,4-dioxane-2,5-dione, with L-lactide. The glycolide­-lactide copolymers include poly(glycolide-L-lactide) copolymers formed utilizing a monomer mole ratio of glycolic acid to L-lactic acid ranging from 5:95 to 95:5 and preferably a monomer mole ratio of glycolic acid to L-lactic acid ranging from 45:65 to 95:5. The glycolide-caprolactone copolymers include glycolide and ε-caprolactone block copolymer, e.g., Monocryl or Poliglecaprone.
    • 本发明提供生物活性聚合物组合物,其可配制成通过调节组合物的各种组分以受控的速率释放伤口愈合剂。 组合物可用于外部伤口敷料中,作为用于将伤口愈合剂递送至内部身体部位的聚合物植入物,或作为可植入手术装置的表面上的涂层,以递送共价连接到 生物相容的可生物降解聚合物和/或嵌入在水凝胶内。 还提供了使用本发明生物活性聚合物组合物促进伤口,特别是慢性伤口的自然愈合的方法。 可用于形成血液相容的亲水层或涂层的可生物降解的共聚物聚酯的实例包括共聚酯酰胺,共聚酯氨基甲酸酯,乙交酯 - 丙交酯共聚物,乙交酯 - 己内酯共聚物,聚-3-羟基丁酸戊酯共聚物和环状二酯单体的共聚物, 3(S)[(烷氧基羰基)甲基] -1,4-二恶烷-2,5-二酮与L-丙交酯。 乙交酯 - 丙交酯共聚物包括使用乙醇酸与L-乳酸的单体摩尔比在5:95至95:5范围内形成的聚(乙交酯-L-丙交酯)共聚物,优选乙醇酸与L-乳酸的单体摩尔比, 乳酸范围为45:65至95:5。 乙交酯 - 己内酯共聚物包括乙交酯和ε-己内酯嵌段共聚物,例如Monocryl或Poliglecaprone。
    • 9. 发明申请
    • WOUND HEALING POLYMER COMPOSITIONS AND METHODS FOR USE THEREOF
    • 创伤治疗聚合物组合物及其使用方法
    • WO2005112587A3
    • 2009-04-09
    • PCT/US2005016678
    • 2005-05-12
    • MEDIVAS LLCCARPENTER KENNETH WZHANG HUASHIMCCARTHY BRENDAN JSZINAI ISTVANTURNELL WILLIAM GGOPALAN SINDHU MKATSARAVA RAMAZ
    • CARPENTER KENNETH WZHANG HUASHIMCCARTHY BRENDAN JSZINAI ISTVANTURNELL WILLIAM GGOPALAN SINDHU MKATSARAVA RAMAZ
    • A61K47/00
    • A61K35/44A61K9/0024A61K38/00A61K47/34A61K47/59A61K47/593A61K47/595A61L15/26A61L15/44A61L15/60A61L15/64A61L26/0019A61L26/0066A61L31/10A61L31/148A61L2300/252A61L2300/412A61L2300/414A61L2300/416A61L2300/604A61L2300/64C08L77/12C08L79/02
    • The present invention provides bioactive polymer compositions that can be formulated to release a wound healing agent at a controlled rate by adjusting the various components of the composition. The composition can be used in an external wound dressing, as a polymer implant for delivery of the wound healing agent to an internal body site, or as a coating on the surface of an implantable surgical device to deliver wound healing agents that are covalently attached to a biocompatible, biodegradable polymer and/or embedded within a hydrogel. Methods of using the invention bioactive polymer compositions to promote natural healing of wounds, especially chronic wounds, are also provided. Examples of biodegradable copolymer polyesters useful in forming the blood­-compatible, hydrophilic layer or coating include copolyester amides, copolyester urethanes, glycolide-lactide copolymers, glycolide-caprolactone copolymers, poly-3-hydroxy butyrate­valerate copolymers, and copolymers of the cyclic diester monomer, 3­(S)[(alkyloxycarbonyl)methyl]-1,4-dioxane-2,5-dione, with L-lactide. The glycolide­-lactide copolymers include poly(glycolide-L-lactide) copolymers formed utilizing a monomer mole ratio of glycolic acid to L-lactic acid ranging from 5:95 to 95:5 and preferably a monomer mole ratio of glycolic acid to L-lactic acid ranging from 45:65 to 95:5. The glycolide-caprolactone copolymers include glycolide and e-caprolactone block copolymer, e.g., Monocryl or Poliglecaprone.
    • 本发明提供生物活性聚合物组合物,其可配制成通过调节组合物的各种组分以受控的速率释放伤口愈合剂。 组合物可以用作外部伤口敷料,作为用于将伤口愈合剂递送到内部身体部位的聚合物植入物,或者作为可植入手术装置的表面上的涂层,以递送共价连接到 生物相容的,可生物降解的聚合物和/或嵌入在水凝胶内。 还提供了使用本发明生物活性聚合物组合物促进伤口,特别是慢性伤口的自然愈合的方法。 可用于形成血液相容的亲水层或涂层的可生物降解的共聚物聚酯的实例包括共聚酯酰胺,共聚酯氨基甲酸酯,乙交酯 - 丙交酯共聚物,乙交酯 - 己内酯共聚物,聚-3-羟基丁酸戊酯共聚物,以及环状二酯单体的共聚物, 3(S)[(烷氧基羰基)甲基] -1,4-二恶烷-2,5-二酮与L-丙交酯。 乙交酯 - 丙交酯共聚物包括使用乙醇酸与L-乳酸的单体摩尔比为5:95至95:5的聚(乙交酯-L-丙交酯)共聚物,优选乙醇酸与L-乳酸的单体摩尔比, 乳酸范围为45:65至95:5。 乙交酯 - 己内酯共聚物包括乙交酯和ε-己内酯嵌段共聚物,例如Monocryl或Poliglecaprone。